The Carnitine Palmitoyltransferase 1A Inhibitor Teglicar Shows Promising Antitumour Activity against Canine Mammary Cancer Cells by Inducing Apoptosis

• Príomhchruthaitheoirí: Nunzio Antonio Cacciola (Údar), Fabrizia Sepe (Údar), Salvatore Fioriniello (Údar), Orsolina Petillo (Údar), Sabrina Margarucci (Údar), Marcello Scivicco (Údar), Gianfranco Peluso (Údar), Anna Balestrieri (Údar), Giovanna Bifulco (Údar), Brunella Restucci (Údar), Lorella Severino (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: MDPI AG, 2023-07-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Canine mammary tumours (CMTs) are the most common cancer in intact female dogs. In addition to surgery, additional targeted and non-targeted therapies may offer survival benefits to these patients. Therefore, exploring new treatments for CMT is a promising area in veterinary oncology. CMT cells have...